Overview of ongoing trials testing oral beta-blocker therapy in patients with myocardial infarction
| Trial . | Study chair . | Clinical trials identifier . | LVEF cut-off (inclusion or exclusion) criteria . | Status . |
|---|---|---|---|---|
| REBOOT (TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fraction | Dr Borja Ibanez | NCT03596385 | Inclusion if LVEF >40% | Recruiting |
| BETAMI (BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function | Dr Dan Atar | NCT03646357 | Exclusion if LVEF <40% | Recruiting |
| DANBLOCK (Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction | Dr Ewa Prescott | NCT03778554 | Inclusion if LVEF > 40% | Recruiting |
| AβYSS (assessment of β-blocker interruption after uncomplicated MI on safety and symptomatic cardiac events requiring hospitalization) | Dr Johanne Silvain | NCT03498066 | Exclusion if LVEF <40% | Recruiting |
| REDUCe (Randomized Evaluation of Decreased Usage of Betablockers After Myocardial Infarction) | Dr Tomas Jernberg | NCT03278509 | Inclusion if LVEF ≥50% | Recruiting |
| Trial . | Study chair . | Clinical trials identifier . | LVEF cut-off (inclusion or exclusion) criteria . | Status . |
|---|---|---|---|---|
| REBOOT (TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fraction | Dr Borja Ibanez | NCT03596385 | Inclusion if LVEF >40% | Recruiting |
| BETAMI (BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function | Dr Dan Atar | NCT03646357 | Exclusion if LVEF <40% | Recruiting |
| DANBLOCK (Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction | Dr Ewa Prescott | NCT03778554 | Inclusion if LVEF > 40% | Recruiting |
| AβYSS (assessment of β-blocker interruption after uncomplicated MI on safety and symptomatic cardiac events requiring hospitalization) | Dr Johanne Silvain | NCT03498066 | Exclusion if LVEF <40% | Recruiting |
| REDUCe (Randomized Evaluation of Decreased Usage of Betablockers After Myocardial Infarction) | Dr Tomas Jernberg | NCT03278509 | Inclusion if LVEF ≥50% | Recruiting |
LVEF, left ventricular ejection fraction.
Overview of ongoing trials testing oral beta-blocker therapy in patients with myocardial infarction
| Trial . | Study chair . | Clinical trials identifier . | LVEF cut-off (inclusion or exclusion) criteria . | Status . |
|---|---|---|---|---|
| REBOOT (TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fraction | Dr Borja Ibanez | NCT03596385 | Inclusion if LVEF >40% | Recruiting |
| BETAMI (BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function | Dr Dan Atar | NCT03646357 | Exclusion if LVEF <40% | Recruiting |
| DANBLOCK (Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction | Dr Ewa Prescott | NCT03778554 | Inclusion if LVEF > 40% | Recruiting |
| AβYSS (assessment of β-blocker interruption after uncomplicated MI on safety and symptomatic cardiac events requiring hospitalization) | Dr Johanne Silvain | NCT03498066 | Exclusion if LVEF <40% | Recruiting |
| REDUCe (Randomized Evaluation of Decreased Usage of Betablockers After Myocardial Infarction) | Dr Tomas Jernberg | NCT03278509 | Inclusion if LVEF ≥50% | Recruiting |
| Trial . | Study chair . | Clinical trials identifier . | LVEF cut-off (inclusion or exclusion) criteria . | Status . |
|---|---|---|---|---|
| REBOOT (TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fraction | Dr Borja Ibanez | NCT03596385 | Inclusion if LVEF >40% | Recruiting |
| BETAMI (BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function | Dr Dan Atar | NCT03646357 | Exclusion if LVEF <40% | Recruiting |
| DANBLOCK (Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction | Dr Ewa Prescott | NCT03778554 | Inclusion if LVEF > 40% | Recruiting |
| AβYSS (assessment of β-blocker interruption after uncomplicated MI on safety and symptomatic cardiac events requiring hospitalization) | Dr Johanne Silvain | NCT03498066 | Exclusion if LVEF <40% | Recruiting |
| REDUCe (Randomized Evaluation of Decreased Usage of Betablockers After Myocardial Infarction) | Dr Tomas Jernberg | NCT03278509 | Inclusion if LVEF ≥50% | Recruiting |
LVEF, left ventricular ejection fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
